Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperglycemia and cardiovascular events].

C A Schneider1, B Gallwitz, M Hanefeld

  • 1Klinik III für Innere Medizin, Universität zu Köln. christian.schneider@medizin.uni-koeln.de

Deutsche Medizinische Wochenschrift (1946)
|November 16, 2004
PubMed
Summary

Abnormal glucose metabolism, including diabetes mellitus, significantly increases cardiovascular risk. Early detection and treatment of glucose abnormalities, particularly with intensive insulin therapy in acute myocardial infarction patients, can reduce cardiac events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial.

NPJ digital medicine·2021
Same author

Glycaemic Control in Diabetes.

Handbook of experimental pharmacology·2021
Same author

The natural history of classic galactosemia: lessons from the GalNet registry.

Orphanet journal of rare diseases·2019
Same author

[Diabetes mellitus at the interface between pediatric and adult medicine].

Der Internist·2018
Same author

[Cardiovascular risk in gout patients : Cardiovascular Safety of Febuxostat or Allopurinol in Participants with Gout and Cardiovascular Comorbidities (CARES)].

Der Internist·2018
Same author

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials.

Diabetic medicine : a journal of the British Diabetic Association·2017

Area of Science:

  • Endocrinology and Cardiology
  • Metabolic Syndrome Research

Context:

  • Cardiovascular disease (CVD) risk is influenced by traditional factors like hypertension and smoking.
  • Emerging evidence highlights glucose metabolism abnormalities, such as diabetes mellitus and impaired glucose tolerance, as significant CVD risk factors.
  • Approximately 8% of the general population and up to 60% of coronary artery disease patients exhibit glucose metabolism abnormalities, a prevalence expected to rise with aging and increasing obesity.

Purpose:

  • To underscore the role of glucose metabolism disorders as critical cardiovascular risk factors.
  • To elucidate the mechanisms by which hyperglycemia damages the endothelium.
  • To emphasize the benefits of early detection and glucose-normalizing therapies in mitigating cardiovascular events.

Summary:

Related Experiment Videos

  • Abnormal glucose concentrations contribute to endothelial dysfunction through oxidative stress, inflammation, and procoagulant factor activation.
  • Therapeutic interventions aimed at normalizing blood glucose levels are anticipated to lower the incidence of cardiovascular events in affected individuals.
  • Early and intensive insulin therapy in diabetic patients experiencing acute myocardial infarction has demonstrated improved patient outcomes.

    • Impact:

    • Highlights the critical need for integrated cardiovascular and diabetes care.
    • Suggests that managing glucose metabolism abnormalities is a key strategy for primary and secondary CVD prevention.
    • Underscores the potential for improved patient outcomes through proactive screening and management of glucose abnormalities in at-risk populations.